Back |
home / stock / rytm / rytm message board
Subject | By | Source | When |
---|---|---|---|
For some reason it is tanking now -sale | Amatuer17 | investorshub | 01/26/2021 6:12:28 PM |
$RYTM is not cheap as it has market | midastouch017 | investorshub | 01/26/2021 4:34:29 PM |
You can actually wait for some time and | Amatuer17 | investorshub | 01/26/2021 4:19:37 PM |
I missed out this one! | midastouch017 | investorshub | 01/26/2021 1:29:54 PM |
Just amazing results - they are starting new | Amatuer17 | investorshub | 01/26/2021 1:25:59 PM |
Head the conf call - It was good | Amatuer17 | investorshub | 12/22/2020 10:53:03 PM |
Phase 3 results - BBS stat significant -AL | Amatuer17 | investorshub | 12/22/2020 1:02:23 PM |
znewcar1: RYTM 21% v1,6M c29.27 f44,2M H31.24 | znewcar1 | investorshangout | 11/27/2020 7:43:03 PM |
Finally - Approval Rhythm Pharmaceuticals Announces FDA Approval of | Amatuer17 | investorshub | 11/27/2020 12:44:56 PM |
Thats a big run with PDUFA being in | grich1 | investorshub | 08/30/2020 6:53:04 PM |
Good call! | midastouch017 | investorshub | 08/28/2020 1:45:53 PM |
What is happening? Looks good | Amatuer17 | investorshub | 08/27/2020 6:17:51 PM |
Not so sure the last few years. | midastouch017 | investorshub | 08/10/2020 6:43:30 AM |
$RYTM is not cheap as it has market | Amatuer17 | investorshub | 08/10/2020 2:59:43 AM |
Not so sure the last few years. But | pennyrich | investorshub | 08/09/2020 7:13:09 PM |
Sure. A free country, isn't it? | midastouch017 | investorshub | 08/09/2020 7:06:30 PM |
Can anyone play??? | pennyrich | investorshub | 08/09/2020 6:41:27 PM |
Thanks for the heads up Amatuer17, | midastouch017 | investorshub | 08/08/2020 12:35:15 PM |
Welcome to the board. Hope we all make | Amatuer17 | investorshub | 08/08/2020 12:29:39 PM |
News, Short Squeeze, Breakout and More Instantly...
Rhythm Pharmaceuticals Inc. Company Name:
RYTM Stock Symbol:
NASDAQ Market:
Rhythm Pharmaceuticals Inc. Website:
- European Commission decision anticipated in the second half of 2024 - BOSTON, June 28, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rar...
2024-06-14 11:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
- Participants from the completed Phase 2 hypothalamic obesity trial reported positive changes in sleep, energy levels during setmelanotide therapy in qualitative interviews - - Separate analysis of patients across MC4R pathway diseases showed one year of treatment with setmelanotide im...